IP Library Granted Patent US 11,517,554
Granted Patent B2
US 11,517,554 · App. 16/942,312 · Granted Dec 6, 2022

Method for preventing or treating Alzheimer's disease

Inventor: Charles A. Dinarello (Boulder, CO)
Assignee: OLATEC THERAPEUTICS LLC
A61K31/275A61K9/0053A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,517,554
App. No.
16/942,312
Granted
Dec 6, 2022
Kind
B2
Abstract

The present invention is directed to a method for preventing and/or treating Alzheimer's disease. The method comprises administering to a subject in need thereof an effective amount of dapansutrile. The method reduces neuroinflammation and improves the cognitive functions such as learning and memory processes of the subject. Dapansutrile can be administered to the subject orally at a dose of 100-2000 mg/day for 3 months to 5 years or longer.

Claims (11)

1. A method for treating Alzheimer's disease, comprising the step of:

administering to a subject in need thereof an effective amount of dapansutrile, or a pharmaceutically acceptable solvate thereof.

2. The method according to claim 1 , wherein said method reduces neuroinflammation in the subject.

3. The method according to claim 1 , wherein said method improves the cognitive functions of the subject.

4. The method according to claim 1 , wherein said method improves learning and memory processes of the subject.

5. The method according to claim 1 , wherein dapansutrile is administered to the subject every 1-3 days for 3 months to 5 years.

6. The method according to claim 1 , wherein dapansutrile is administered to the subject 100-2000 mg/day.

7. The method according to claim 1 , wherein the subject is identified by family history, generic screening, clinical signs of memory loss, and/or brain scan.

8. The method according to claim 1 , wherein said compound is administered by systemic administration.

9. The method according to claim 8 , wherein said compound is administered by oral administration.

10. The method according to claim 1 , comprising administering to the subject an effective amount of dapansutrile.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2020
From: DINARELLO, CHARLES A.
To: OLATEC THERAPEUTICS LLC
Reel/Frame 053345/0690 →
Continuity (3)
Continuation PCTUS2019016012 · Jan 31, 2019
Provisional Application 62624637 · Jan 31, 2018
Related Publication 20200352897A1 · Nov 12, 2020